Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
05/28/2009 | US20090136506 Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target |
05/28/2009 | US20090136503 Trail receptor-binding agents and uses of the same |
05/28/2009 | US20090136495 useful therapeutically for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and/or hematocrit in a human; anemia |
05/28/2009 | US20090136491 IL-17 homologous polypeptides and therapeutic uses thereof |
05/28/2009 | US20090136490 Ovr110 antibody compositions and methods for use |
05/28/2009 | US20090136484 Novel antibody molecules and nucleic acids |
05/28/2009 | US20090136483 Compositions and Methods for Binding Lysophosphatidic Acid |
05/28/2009 | US20090136479 Ubiquitin-like protein isg15 for hiv inhibition |
05/28/2009 | US20090136475 Immunokinases |
05/28/2009 | US20090136470 Regulatory t cells and methods of making and using same |
05/28/2009 | US20090136467 Apolipoprotein analogues |
05/28/2009 | US20090136466 Methods for making skin cell derived stem cells |
05/28/2009 | US20090136465 Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof |
05/28/2009 | US20090136463 Schwann Cell Bridge Implants and Phosphodiesterase Inhibitors to Stimulate CNS Nerve Regeneration |
05/28/2009 | US20090136461 Neuronal differentiation method of adult stem cells using small molecules |
05/28/2009 | US20090136459 Compositions for preventing or treating skin defects and methods of use thereof |
05/28/2009 | US20090136458 Renal Carcinoma Cell Line and Uses thereof |
05/28/2009 | US20090136456 Methods of treating neurodegenerative disorders |
05/28/2009 | US20090136447 Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor |
05/28/2009 | US20090136446 Induction of regulatory t cell-resistant helper cd4+ t cells |
05/28/2009 | US20090136431 Stilbene Like Compounds as Novel HDAC Inhibitors |
05/28/2009 | US20090133633 In ovo activation of an egg in the shell |
05/28/2009 | CA2706324A1 Transformation of crambe abyssinica |
05/28/2009 | CA2706293A1 Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof |
05/28/2009 | CA2706201A1 Peptides with capacity to bind to scurfin and applications |
05/27/2009 | EP2062977A1 Fucosyltransferase-gen |
05/27/2009 | EP2062970A1 Compositions for treating an intestinal inflammatory condition |
05/27/2009 | EP2062917A2 Antibodies to erythropoietin receptor and uses thereof |
05/27/2009 | EP2061891A2 Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor |
05/27/2009 | EP2061888A2 Hcv fusion polypeptides |
05/27/2009 | EP2061879A2 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
05/27/2009 | EP2061878A2 Hybrid suppressor trna for vertebrate cells |
05/27/2009 | EP2061877A1 Differentiating of stem cells |
05/27/2009 | EP2061876A2 Transcription factors for differentiation of adult human olfactory progenitor cells |
05/27/2009 | EP2061875A1 Gum coatings for cell culture, methods of manufacture and methods of use |
05/27/2009 | EP2061874A2 Fused stem cells useful for the treatment of diabetes and methods thereof |
05/27/2009 | EP2061873A2 Cell delivery matrices |
05/27/2009 | EP2061814A2 Antibodies and immunoconjugates and uses therefor |
05/27/2009 | EP2061812A1 Method for producing antibodies |
05/27/2009 | EP2061811A2 Variable region sequences of il-31 monoclonal antibodies and methods of use |
05/27/2009 | EP2061527A2 Repair of cartilage tissue |
05/27/2009 | EP2061494A1 Regulation of expression of p140cap protein in tumors |
05/27/2009 | EP2061303A2 Novel rucola plants with cytoplasmic male sterility (cms) |
05/27/2009 | EP1951036A4 The use of apoptotic cells ex vivo to generate regulatory t-cells |
05/27/2009 | EP1788088B1 Vector expressing human n-deacetylase/n-sulfotransferase 2 |
05/27/2009 | EP1575881B1 Alanine 2,3- aminomutase |
05/27/2009 | EP1548032B1 Kdr peptides and vaccines comprising the same |
05/27/2009 | EP1544298B1 Cultured xenopus laevis cell lines expressing mutant adenomatous polyposis coli gene |
05/27/2009 | EP1503681A4 Magnetic embryo transfer |
05/27/2009 | EP1366075B1 New interferon beta-like molecules |
05/27/2009 | EP1343880B1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic bovine |
05/27/2009 | EP1292678B1 G-protein coupled receptors |
05/27/2009 | EP1235915B1 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
05/27/2009 | EP1200476B1 Antitumor antibodies, proteins, and uses thereof |
05/27/2009 | EP1132402B1 Peptide fragments having cell death inhibitory activity |
05/27/2009 | EP0939796B1 Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10 |
05/27/2009 | EP0871487B1 Dendritic cell stimulatory factor |
05/27/2009 | CN101443460A Detection of molecular interactions using a reduced affinityenzyme complementation reporter system |
05/27/2009 | CN101443450A Novel mutation involved in increased tolerance to imidazolinone herbicides in plants |
05/27/2009 | CN101443445A Culture system and method for propagation of human blastocyst-derived stem cells |
05/27/2009 | CN101443444A Bioreactor process control system and method |
05/27/2009 | CN101443053A Scaffold |
05/27/2009 | CN101443047A Inhibition of Li expression in mammalian cells |
05/27/2009 | CN101443036A Reagents and methods for cancer treatment and prevention |
05/27/2009 | CN101443023A Method for treating angiocarpy disease using fat tissue source cell |
05/27/2009 | CN101442902A Transgenic plants with enhanced agronomic traits |
05/27/2009 | CN101441222A Method for detecting Beta accompany glycinin and specific antibody and reagent kit thereof |
05/27/2009 | CN101440374A sd1 gene involved in plant semidwarfing and uses thereof |
05/27/2009 | CN101440360A Ease variants and compositions |
05/27/2009 | CN101440358A Culture for preventing serum-free microcarrier cell from aggregating and preparation thereof |
05/27/2009 | CN101438678A Method for quickly propagating stem node of pokeberry |
05/27/2009 | CN100491535C Chuancao-II Laomangmai wheat pest-resisting gene transferring technology |
05/27/2009 | CN100491525C Novel amylolytic enzyme extracted from bacillus SP.A7-7(DSM 12368)and washing and cleaning agents containing this novel amylolytic enzyme |
05/27/2009 | CN100491398C Method of manufacturing human antibody possessing bioreceptor synergist, antagonist and/or inverse synergist |
05/27/2009 | CN100491397C Method and compositions for generating human monoclonal antibodies |
05/27/2009 | CN100490902C Photochemical internalization for virus-mediated molecule delivery into the cyosol |
05/27/2009 | CN100490895C CD40-binding APC-activating molecules |
05/27/2009 | CN100490636C Method for obtaining lily distant hybrid by using rescue isolated culture of buds |
05/26/2009 | US7538261 Maize promoter active in silks, stalk nodes, roots and leaf sheaths |
05/26/2009 | US7538207 Polyepitope carrier protein |
05/26/2009 | US7538203 Expression vector comprising nucleotide sequences coding legumin-like proteins for use as tool in diagnosing and treating nut allergies |
05/26/2009 | US7538200 Thermal tolerant avicelase from Acidothermus cellulolyticus |
05/26/2009 | US7538195 Antibodies that bind to human insulin-like growth factor-I receptor; particularly, antibodies that inhibit the cellular functions of the IGF-I receptor; cancer treatment |
05/26/2009 | US7538095 Genetic inhibition by double-stranded RNA |
05/26/2009 | US7538088 Method for inhibiting angiogenesis by administration of the extracellular domain of D1-1 polypeptide |
05/26/2009 | US7538086 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders |
05/26/2009 | US7537931 a cancer which expresses epidermal growth factor receptor; blocking ligand activation of a receptor; binding of monoclonal antibody 2C4 to ErbB2; chemotherapeutic agents are 5-fluorouracil leucovorin, levamisole |
05/26/2009 | US7537930 Mammalian cell lines for increasing longevity and protein yield from a cell culture |
05/26/2009 | US7537929 Nucleotide sequences coding serine protease inhibitor for use in targeting and killing insect cell |
05/26/2009 | US7537928 Expression vector comprising nucleotide sequences coding potassium chanel protein for use as tools in identifying modulator for prevention and treatment of cardiovascular/myocardial disorders |
05/26/2009 | US7537916 Using immortalized cells comprising vector coding cytomegalo viral regulatory sequences to propagate immunoglobulins |
05/26/2009 | US7537904 Animal tissue comprising aryl hydrocarbon, estrogen, androgen and/or thyroid hormone receptor for use as screening tool in identify gene expression activators |
05/26/2009 | US7537901 Extracellular serine protease |
05/26/2009 | US7537885 Composition for maintaining organ and cell viability |
05/26/2009 | US7537780 Method for preparing and implanting a cartilage construct to treat cartilage lesions |
05/26/2009 | US7537771 Produces an immune response which is protective against Bacillus anthracis |
05/26/2009 | US7537763 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
05/26/2009 | US7537756 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
05/26/2009 | CA2497857C Novel p-selectin ligand protein |
05/26/2009 | CA2422907C Microstructures for treating and conditioning skin |